Matches in Nanopublications for { ?s ?p "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP279616.RA_0A6zLe8bZRVk3nAtaRnP5SNKAFlf6uSXI-3vrzS2g0130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279616.RA_0A6zLe8bZRVk3nAtaRnP5SNKAFlf6uSXI-3vrzS2g0130_provenance.
- NP306460.RA0ceAiWw-qu06uHt1f_b-S6emTLpyKI2MyWYyS1aahzo130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306460.RA0ceAiWw-qu06uHt1f_b-S6emTLpyKI2MyWYyS1aahzo130_provenance.
- NP655318.RAN2ab-_j-WMz5eN5pQXfEaV3ISdoaXyVohWyuO5qv1XY130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655318.RAN2ab-_j-WMz5eN5pQXfEaV3ISdoaXyVohWyuO5qv1XY130_provenance.
- NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315560.RAAnf_GI0nSknBmzYmPc7Ma6blstUMEFDooNFllU0Ltz8130_provenance.
- NP611512.RAWV6cDfPO0oSzvAip9-wWnMzBsGMh1hHatezR6Ljd64Y130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611512.RAWV6cDfPO0oSzvAip9-wWnMzBsGMh1hHatezR6Ljd64Y130_provenance.
- assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP315564.RAXKQz7qUO0cUm3aPQ9y2CLyDyyo4xK6zWFoT_ycjIlXI130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315564.RAXKQz7qUO0cUm3aPQ9y2CLyDyyo4xK6zWFoT_ycjIlXI130_provenance.
- assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP302329.RAoCchuWx_xQttywMEn_I1W5rE8uUzZ8i3ct2arhfJRgM130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302329.RAoCchuWx_xQttywMEn_I1W5rE8uUzZ8i3ct2arhfJRgM130_provenance.
- NP926147.RAGaZIv9FBd4ckdBbxTIQD6LglG2qyjr5qsFWWsHKdXbo130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926147.RAGaZIv9FBd4ckdBbxTIQD6LglG2qyjr5qsFWWsHKdXbo130_provenance.
- NP315561.RAlV_4U618YELR7ItIWND_ghHZF6S8j91J70bgVPOhMCs130_assertion description "[These are the inactivation of cyclin-dependent kinase inhibitors (p15, p16, and p21WAF/CIP1) in low-grade TCC and early TP53-mediated abnormalities in high-grade TCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315561.RAlV_4U618YELR7ItIWND_ghHZF6S8j91J70bgVPOhMCs130_provenance.